The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Nischalke, Hans Dieter ^a   Berger, Cordula ^a   Luda, Carolin ^a   Berg, Thomas ^b   Müller, Tobias ^c   Grünhage, Frank ^d   Lammert, Frank ^d   Coenen, Martin ^a   Krämer, Benjamin ^a   Körner, Christian ^a   Vidovic, Natascha ^a   Oldenburg, Johannes ^a   Nattermann, Jacob ^a   Sauerbruch, Tilman ^a   Spengler, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS C; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PNPLA3 GENE; RISK ASSESSMENT; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MIDDLE AGED; RISK FACTOR;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

ADIPONUTRIN, HUMAN; MEMBRANE PROTEIN; TRIACYLGLYCEROL LIPASE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS C; HUMANS; LIPASE; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 80455174482     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027087     Document Type: Article

References (28)

1. Altekruse SF, McGlynn KA, Reichman ME, (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27: 1485-1491.
2. Schutte K, Bornschein J, Malfertheiner P, (2009) Hepatocellular carcinoma-epidemiological trends and risk factors. Dig Dis 27: 80-92.
3. Yang JD, Roberts LR, Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol 7: 448-458.
4. Bosch FX, Ribes J, Diaz M, Cleries R, (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16.
5. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, et al. (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40: 1461-1465.
6. Petit JM, Guiu B, Masson D, Duvillard L, Jooste V, et al. (2010) Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetes. J Clin Endocrinol Metab 95: E430-436.
7. Rae-Whitcombe SM, Kennedy D, Voyles M, Thompson MP, (2010) Regulation of the promoter region of the human adiponutrin/PNPLA3 gene by glucose and insulin. Biochem Biophys Res Commun 402: 767-772.
8. Speliotes EK, Butler JL, Palmer CD, Voight BF, Hirschhorn JN, (2010) PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 52: 904-912.
9. Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, et al. (2010) I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 52: 1274-1280.
10. Santoro N, Kursawe R, D'Adamo E, Dykas DJ, Zhang CK, et al. (2010) A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology 52: 1281-1290.
11. Goran MI, Walker R, Le KA, Mahurkar S, Vikman S, et al. (2010) Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents. Diabetes 59: 3127-3130.
12. Kollerits B, Coassin S, Beckmann ND, Teumer A, Kiechl S, et al. (2009) Genetic evidence for a role of adiponutrin in the metabolism of apolipoprotein B-containing lipoproteins. Hum Mol Genet 18: 4669-4676.
13. Romeo S, Sentinelli F, Dash S, Yeo GS, Savage DB, et al. (2010) Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Int J Obes (Lond) 34: 190-194.
14. Sookoian S, Castano GO, Burgueno AL, Gianotti TF, Rosselli MS, et al. (2009) A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res 50: 2111-2116.
15. Tian C, Stokowski RP, Kershenobich D, Ballinger DG, Hinds DA, (2010) Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet 42: 21-23.
16. Krawczyk M, Grunhage F, Zimmer V, Lammert F, (2011) Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: Non-invasive elastography-based study in chronic liver disease. J Hepatol 55: 299-306.
17. Stickel F, Buch S, Lau K, zu Schwabedissen HM, Berg T, et al. (2011) Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians. Hepatology 53: 86-95.
18. Trepo E, Gustot T, Degre D, Lemmers A, Verset L, et al. (2011) Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. J Hepatol 2011 Feb 18. [Epub ahead of print].
19. Corradini SG, Burza MA, Molinaro A, Romeo S, (2011) Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma. Hepatology 53: 1776; author reply 1777.
20. Valenti L, Rumi M, Galmozzi E, Aghemo A, Menico BD, et al. (2011) Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Hepatology 53: 791-9.
21. Falleti E, Fabris C, Cmet S, Cussigh A, Bitetto D, et al. (2011) PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. Liver Int 2011 Apr 19. [Epub ahead of print].
22. Sanyal AJ, (2005) Review article: non-alcoholic fatty liver disease and hepatitis C-risk factors and clinical implications. Aliment Pharmacol Ther 22 (Suppl 2): 48-51.
23. Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, et al. (2004) Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 279: 48968-48975.
24. He S, McPhaul C, Li JZ, Garuti R, Kinch L, et al. (2010) A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 285: 6706-6715.
25. Chen W, Chang B, Li L, (2010) Chan L Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology 52: 1134-1142.
26. Browning JD, Cohen JC, Hobbs HH, (2010) Patatin-like phospholipase domain-containing 3 and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease. Hepatology 52: 1189-1192.
27. Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ, (2010) The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 52: 894-903.
28. Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, et al. (2010) Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 51: 1209-1217.